Related Experiment Video
Updated: May 14, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Antidepressants normalize the default mode network in patients with dysthymia
Jonathan Posner1, David J Hellerstein, Inbal Gat
1Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York, New York 10032, USA. posnerj@nyspi.columbia.edu
JAMA Psychiatry
|February 8, 2013
Summary
Dysthymic disorder (DD) shows increased default mode network (DMN) connectivity, similar to major depressive disorder. Antidepressant treatment with duloxetine normalized this DMN connectivity, suggesting a key mechanism for treatment efficacy.
Area of Science:
- Neuroscience
- Psychiatry
- Radiology
Background:
- The default mode network (DMN) is crucial for resting-state brain activity.
- Increased DMN functional connectivity is observed in major depressive disorder (MDD).
- DMN connectivity in dysthymic disorder (DD) and the impact of antidepressants remain understudied.
Purpose of the Study:
- To investigate DMN functional connectivity in individuals with DD compared to healthy controls (HC).
- To examine the effects of a 10-week antidepressant treatment (duloxetine) on DMN connectivity in DD patients.
Main Methods:
- Resting-state functional connectivity magnetic resonance imaging (fMRI) was employed.
- 41 participants with DD and 25 HC participants were included.
- A 10-week double-blind, placebo-controlled trial of duloxetine was conducted for DD patients.
Main Results:
- Individuals with DD exhibited heightened DMN functional connectivity at baseline compared to HC.
- Treatment with duloxetine, but not placebo, led to normalization of DMN connectivity.
- 32 of 41 DD participants completed the trial and follow-up MRI scans.
Conclusions:
- Elevated DMN connectivity in DD mirrors findings in MDD, suggesting a role in depressive illness pathophysiology.
- Antidepressant treatment normalizing DMN connectivity indicates a potential therapeutic pathway.
- These findings highlight the DMN's importance in both chronic and acute depressive states.
Related Concept Videos
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...